Opinion: Reducing Foodborne Illness

New testing technologies and improved communication among regulatory agencies are making strides in the fight against foodborne disease.

Written byJ. Stan Bailey
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA COMMONS, IVAN ATMANAGARA

As evidenced by the E. coli outbreak in Europe earlier this year, which claimed dozens of lives and sickened thousands more, bacterial contamination of foods remains a significant problem. This outbreak clearly demonstrated that, despite recent improvements in technologies to detect and trace foodborne outbreaks, it will take continual advances in knowledge and techniques to prevent future epidemics.

Each year, roughly one out of six Americans, or 48 million people, contract foodborne illnesses, according to estimates from the United States Centers for Disease Control and Prevention (CDC). The economic impact of foodborne illness is staggering, with a recent report from the University of Florida’s Emerging Pathogens Institute concluding that five leading pathogens —Campylobacter, Salmonella, Listeria monocytogenes, Toxoplasma gondii and norovirus — cost the nation $12.7 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies